Repp R, Borkhardt A, Gossen R, Kreuder J, Hammermann J, Lampert F
Children's Hospital, University of Giessen, Germany.
Biotechniques. 1995 Jul;19(1):84, 86-8, 90.
The exponential character of PCR amplification may compromise quantitative assays because it multiplies minor sample-to-sample variations. To overcome these problems, several authors have used recombinant standard DNA or RNA molecules to be spiked into the samples in a dilution series of known copy numbers before co-amplification by PCR. To obtain an equal efficacy of reverse transcription and PCR amplification, standard and template molecules should be highly homologous. However, the limited resolution of commonly used agarose gel electrophoresis requires rather large differences in size and nucleotide sequence to separate both molecules from each other after PCR. Due to a much higher resolution, automatic post-PCR analyzing systems based on laser-induced fluorescence may help to overcome these difficulties. For using the capabilities of these systems in quantitative competitive RT-PCR, we developed a protocol to construct recombinant RNA standard molecules that only differ from the target sequence by a small deletion of 8 nucleotides. It is based on PCR-induced mutagenesis and solid-phase in vitro transcription. This protocol was applied to quantify multidrug resistance gene (MDRI) mRNA in malignant cells, but it can easily be adapted to any gene of interest.
PCR扩增的指数特性可能会影响定量分析,因为它会放大样本间的微小差异。为克服这些问题,一些作者在通过PCR进行共扩增之前,使用重组标准DNA或RNA分子,将其按已知拷贝数的稀释系列加入样本中。为了获得逆转录和PCR扩增的同等效率,标准分子和模板分子应具有高度同源性。然而,常用的琼脂糖凝胶电泳分辨率有限,需要大小和核苷酸序列有相当大的差异,才能在PCR后将两种分子彼此分离。由于分辨率更高,基于激光诱导荧光的自动PCR后分析系统可能有助于克服这些困难。为了在定量竞争性RT-PCR中利用这些系统的功能,我们开发了一种构建重组RNA标准分子的方案,该分子与靶序列仅相差8个核苷酸的小缺失。它基于PCR诱导的诱变和固相体外转录。该方案用于定量恶性细胞中的多药耐药基因(MDRI)mRNA,但它可以很容易地适用于任何感兴趣的基因。